BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li MY, Deng H, Zhao JM, Dai D, Tan XY. PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. World J Gastroenterol 2003; 9(6): 1220-1226 [PMID: 12800228 DOI: 10.3748/wjg.v9.i6.1220] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Wagner N, Wagner KD. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer. Cells 2022;11:2432. [PMID: 35954274 DOI: 10.3390/cells11152432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Russo C, Lavorgna M, Nugnes R, Orlo E, Isidori M. Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin. Sci Rep 2021;11:22494. [PMID: 34795379 DOI: 10.1038/s41598-021-01975-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Chang SN, Lee JM, Oh H, Kim U, Ryu B, Park JH. Troglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3. Oncol Lett 2018;16:5482-8. [PMID: 30250621 DOI: 10.3892/ol.2018.9278] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
4 To KKW, Wu WKK, Loong HHF. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy. Eur J Pharmacol 2018;823:19-26. [PMID: 29378193 DOI: 10.1016/j.ejphar.2018.01.036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
5 Houshmand G, Mansouri MT, Naghizadeh B, Hemmati AA, Hashemitabar M. Potentiation of indomethacin-induced anti-inflammatory response by pioglitazone in carrageenan-induced acute inflammation in rats: Role of PPARγ receptors. Int Immunopharmacol 2016;38:434-42. [PMID: 27376854 DOI: 10.1016/j.intimp.2016.06.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ye J, Yin L, Xie P, Wu J, Huang J, Zhou G, Xu H, Lu E, He X. Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro. Onco Targets Ther 2015;8:1211-8. [PMID: 26060406 DOI: 10.2147/OTT.S79899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
7 Herrigel DJ, Moss RA. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. Postgrad Med. 2014;126:106-118. [PMID: 25414939 DOI: 10.3810/pgm.2014.10.2825] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
8 Wang J, Yuan L, Xiao H, Wang C, Xiao C, Wang Y, Liu X. A novel mechanism for momordin Ic-induced HepG2 apoptosis: involvement of PI3K- and MAPK-dependent PPARγ activation. Food Funct 2014;5:859-68. [PMID: 24584198 DOI: 10.1039/c3fo60558b] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
9 Chen S, Liu C, Wang X, Li X, Chen Y, Tang N. 15-Deoxy-Δ(12,14)-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells. Chem Biol Interact 2014;214:26-32. [PMID: 24582817 DOI: 10.1016/j.cbi.2014.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
10 Kostadinova R, Boess F, Applegate D, Suter L, Weiser T, Singer T, Naughton B, Roth A. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. Toxicol Appl Pharmacol. 2013;268:1-16. [PMID: 23352505 DOI: 10.1016/j.taap.2013.01.012] [Cited by in Crossref: 201] [Cited by in F6Publishing: 206] [Article Influence: 20.1] [Reference Citation Analysis]
11 Berger E, Vega N, Vidal H, Geloën A. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival. Biotechnology Journal 2012;7:1395-404. [DOI: 10.1002/biot.201200188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hazra S, Peebles KA, Sharma S, Mao JT, Dubinett SM. The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer. PPAR Res 2008;2008:790568. [PMID: 18769553 DOI: 10.1155/2008/790568] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
13 Borbath I, Horsmans Y. The Role of PPARgamma in Hepatocellular Carcinoma. PPAR Res 2008;2008:209520. [PMID: 18509497 DOI: 10.1155/2008/209520] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
14 Raman P, Kaplan BL, Thompson JT, Vanden Heuvel JP, Kaminski NE. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. Mol Pharmacol 2011;80:201-9. [PMID: 21511917 DOI: 10.1124/mol.110.070441] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
15 To AK, Chen GG, Chan UP, Ye C, Yun JP, Ho RL, Tessier A, Merchant JL, Lai PB. ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cells. Biochim Biophys Acta 2011;1813:222-30. [PMID: 20850481 DOI: 10.1016/j.bbamcr.2010.09.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
16 Nakamura YK, Omaye ST. Vitamin E-modulated gene expression associated with ROS generation. Journal of Functional Foods 2009;1:241-52. [DOI: 10.1016/j.jff.2009.02.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
17 Cui W, Hu SX, Tang ZY, Hu KQ. In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice. Anticancer Drugs. 2008;19:891-897. [PMID: 18766003 DOI: 10.1097/CAD.0b013e32830ef8ca] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
18 Wu Y, Guo SW. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells. Fertil Steril 2009;91:2142-7. [PMID: 18571164 DOI: 10.1016/j.fertnstert.2008.04.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
19 Haruna H, Shimizu T, Ohtsuka Y, Yarita Y, Fujii T, Kudo T, Yamashiro Y. Expression of COX-1, COX-2, and PPAR-γ in the gastric mucosa of children with Helicobacter pylori infection. Pediatr Int 2008;50:1-6. [DOI: 10.1111/j.1442-200x.2007.02504.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
20 Liang HL, Ouyang Q. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World J Gastroenterol 2008; 14(1): 114-119 [PMID: 18176972 DOI: 10.3748/wjg.14.114] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
21 Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev Anticancer Ther 2007;7:1405-21. [PMID: 17944566 DOI: 10.1586/14737140.7.10.1405] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 3.8] [Reference Citation Analysis]
22 Zhang Y, Ba Y, Liu C, Sun G, Ding L, Gao S, Hao J, Yu Z, Zhang J, Zen K, Tong Z, Xiang Y, Zhang CY. PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway. Cell Res 2007;17:363-73. [PMID: 17372612 DOI: 10.1038/cr.2007.11] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
23 Borbath I, Leclercq I, Moulin P, Sempoux C, Horsmans Y. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver. Eur J Cancer. 2007;43:1755-1763. [PMID: 17582756 DOI: 10.1016/j.ejca.2007.05.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
24 Hazra S, Batra RK, Tai HH, Sharma S, Cui X, Dubinett SM. Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase. Mol Pharmacol. 2007;71:1715-1720. [PMID: 17412838 DOI: 10.1124/mol.106.033357] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 4.2] [Reference Citation Analysis]
25 Zhang YQ, Tang XQ, Sun L, Dong L, Qin Y, Liu HQ, Xia H, Cao JG. Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor γ. World J Gastroenterol 2007; 13(10): 1534-1540 [PMID: 17461445 DOI: 10.3748/wjg.v13.i10.1534] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
26 Sánchez-Hidalgo M, Martín AR, Villegas I, de la Lastra CA. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Eur J Pharmacol. 2007;562:247-258. [PMID: 17343846 DOI: 10.1016/j.ejphar.2007.01.047] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
27 Ishiguro H, Ishiguro Y, Kubota Y, Uemura H. Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action. Prostate 2007;67:924-32. [DOI: 10.1002/pros.20571] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
28 Ming M, Yu JP, Meng XZ, Zhou YH, Yu HG, Luo HS. Effect of ligand troglitazone on peroxisome proliferator-activated receptor γ expression and cellular growth in human colon cancer cells. World J Gastroenterol 2006; 12(45): 7263-7270 [PMID: 17143939 DOI: 10.3748/wjg.v12.i45.7263] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
29 Schwab M, Reynders V, Ulrich S, Zahn N, Stein J, Schröder O. PPARgamma is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2. Apoptosis. 2006;11:1801-1811. [PMID: 16927016 DOI: 10.1007/s10495-006-9788-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
30 Klopotek A, Hirche F, Eder K. PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2. Exp Biol Med (Maywood) 2006;231:1365-72. [PMID: 16946405 DOI: 10.1177/153537020623100810] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
31 Fulzele SV, Chatterjee A, Shaik MS, Jackson T, Singh M. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model. Pharm Res 2006;23:2094-106. [PMID: 16902813 DOI: 10.1007/s11095-006-9074-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
32 He G, Sung YM, Fischer SM. Troglitazone induction of COX-2 expression is dependent on ERK activation in keratinocytes. Prostaglandins, Leukotrienes and Essential Fatty Acids 2006;74:193-7. [DOI: 10.1016/j.plefa.2005.12.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
33 Nozawa H, Nakao W, Zhao F, Kondo K. Dietary supplement of isohumulones inhibits the formation of aberrant crypt foci with a concomitant decrease in prostaglandin E2 level in rat colon. Mol Nutr Food Res 2005;49:772-8. [DOI: 10.1002/mnfr.200500027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
34 Sánchez-Hidalgo M, Martín AR, Villegas I, Alarcón De La Lastra C. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol. 2005;69:1733-1744. [PMID: 15876425 DOI: 10.1016/j.bcp.2005.03.024] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 5.2] [Reference Citation Analysis]
35 Harada K, Isse K, Kamihira T, Shimoda S, Nakanuma Y. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology 2005;41:1329-38. [PMID: 15880426 DOI: 10.1002/hep.20705] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
36 Knight B, Yeap BB, Yeoh GC, Olynyk JK. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta. Carcinogenesis 2005;26:1782-92. [PMID: 15917308 DOI: 10.1093/carcin/bgi138] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
37 Chen J, Li D, Zhang X, Mehta JL. Tumor necrosis factor-alpha-induced apoptosis of human coronary artery endothelial cells: modulation by the peroxisome proliferator-activated receptor-gamma ligand pioglitazone. J Cardiovasc Pharmacol Ther 2004;9:35-41. [PMID: 15094967 DOI: 10.1177/107424840400900i106] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
38 Bogazzi F, Ultimieri F, Raggi F, Russo D, Vanacore R, Guida C, Brogioni S, Cosci C, Gasperi M, Bartalena L, Martino E. Growth Hormone Inhibits Apoptosis in Human Colonic Cancer Cell Lines: Antagonistic Effects of Peroxisome Proliferator Activated Receptor-γ Ligands. Endocrinology 2004;145:3353-62. [DOI: 10.1210/en.2004-0225] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
39 Liu JW, Li KZ, Dou KF, Song ZS, Su MQ, Yu WB. Effects of COX-2 inhibitor with cisplatin on proliferation and apoptosis of pancreatic cancer cells. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1139-1143 [DOI: 10.11569/wcjd.v12.i5.1139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Zhao CY, Jiang LL, Li L, Deng ZJ, Liang BL, Li JM. Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver disease. World J Gastroenterol 2004; 10(9): 1329-1332 [PMID: 15112352 DOI: 10.3748/wjg.v10.i9.1329] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ohshima T, Koga H, Shimotohno K. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification. J Biol Chem. 2004;279:29551-29557. [PMID: 15123625 DOI: 10.1074/jbc.m403866200] [Cited by in Crossref: 148] [Cited by in F6Publishing: 156] [Article Influence: 7.8] [Reference Citation Analysis]
42 Han S, Roman J. Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growth. Biochem Biophys Res Commun. 2004;314:1093-1099. [PMID: 14751245 DOI: 10.1016/j.bbrc.2004.01.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 3.2] [Reference Citation Analysis]
43 Drouin G, Douillette A, Lacasse P, Paquette B. Effet radiosensibilisateur de l'acide linoléique conjugué chez les cellules cancéreuses du sein MCF-7 et MDA-MB-231. Can J Physiol Pharmacol 2004;82:94-102. [DOI: 10.1139/y04-003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]